Cellectis CLLS
NASDAQ CLLS
$1.38 +0.27 (+24.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2025)

Updated

Cellectis (CLLS) posted Share-based Compensation (IS) of -$987,000 for FY2022, compared with -$3.6 million in FY2021.

Analysis

Cellectis (CLLS) Share-based Compensation (IS) (2015 - 2025) Analysis & Trends

Since FY2015, Cellectis has reported Share-based Compensation (IS) for 8 years.

  • The FY2022 figure stands as the highest annual Share-based Compensation (IS) in data going back to FY2015.
  • Business Quant data shows CLLS's Share-based Compensation (IS) at -$3.6 million in FY2021, -$2.51 million in FY2020, -$7.83 million in FY2019 and -$8.07 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Cellectis 111.38 Mn -642.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1,602.00
Sep 30, 2024 -566.00
Sep 30, 2015 10.53 Mn
Mar 31, 2015 947,929.46
API Access

Cellectis Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=CLLS&period=max&api_key=YOUR_API_KEY